Fulcrum Therapeutics (FULC) Return on Assets (2019 - 2026)
Fulcrum Therapeutics (FULC) posted quarterly Return on Assets of 0.01% for Q2 2026, little changed year-over-year from 0.01% in Q2 2025, and down 3.23% quarter-over-quarter from 0.01% in Q1 2026.
Fulcrum Therapeutics (FULC) Return on Assets (2019 - 2026) Analysis & Trends
Fulcrum Therapeutics (FULC) has reported Return on Assets for 8 consecutive years, with 0.01% the latest figure, recorded in Q2 2026.
- In Q2 2026, Return on Assets changed 0.0% year-over-year to 0.01%; the TTM figure through Jun 2026 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
- Return on Assets declined to 0.01% in Q2 2026 per FULC's latest filing, from 0.01% in the prior quarter.
- Across five years, Return on Assets topped out at 0.0% in Q1 2025 and bottomed at 0.02% in Q2 2022.
- Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.01% in 2026.
- Annual changes were most pronounced in 2022 — Return on Assets decreased 1 bps — and 2023, when it rose 1 bps.
- Fulcrum Therapeutics' Return on Assets stood at 0.01% in 2022, then jumped by 31 bps to 0.01% in 2023, then jumped by 49 bps to 0.0% in 2024, then slumped by 142 bps to 0.01% in 2025, then grew by 8 bps to 0.01% in 2026.
- Business Quant data shows FULC's Return on Assets at 0.01% in Q2 2026, 0.01% in Q1 2026, and 0.01% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.01% |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Fulcrum Therapeutics | 285.31 Mn | 285.31 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |